About Lindis Blood Care
Lindis Blood Care is a company based in Hennigsdorf (Germany) founded in 2006 by Franzpeter Bracht and Horst Lindhofer. It operates as a HealthTech. Lindis Blood Care has raised $1.89 million across 3 funding rounds from investors including Investitionsbank des Landes Brandenburg, Brandenburg Capital and High-Tech Gründerfonds. Lindis Blood Care offers products and services including CATUVAB®. Lindis Blood Care operates in a competitive market with competitors including Hemotune, On Target Laboratories, Huake Precision (Beijing) Medical Technology, Averto Medical and Medcura, among others.
- Headquarter Hennigsdorf, Germany
- Founders Franzpeter Bracht, Horst Lindhofer
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lindis Blood Care Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.89 M (USD)
in 3 rounds
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Lindis Blood Care
Lindis Blood Care offers a comprehensive portfolio of products and services, including CATUVAB®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device removes tumor cells for safer blood transfusions.
Unlock access to complete
Unlock access to complete
Funding Insights of Lindis Blood Care
Lindis Blood Care has successfully raised a total of $1.89M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(13 Dec 2019)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2022 | Amount | Series B - Lindis Blood Care | Valuation | Brandenburg Capital , HTGF |
|
| Dec, 2019 | Amount | Series A - Lindis Blood Care | Valuation | Brandenburg Capital , HTGF |
|
| Dec, 2019 | Amount | Grant - Lindis Blood Care | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lindis Blood Care
Lindis Blood Care has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Investitionsbank des Landes Brandenburg, Brandenburg Capital and High-Tech Gründerfonds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by Brandenburg Capital toward multiple sectors.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location | |
|
Financial support and programs are provided for businesses and housing.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lindis Blood Care
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Lindis Blood Care
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lindis Blood Care Comparisons
Competitors of Lindis Blood Care
Lindis Blood Care operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemotune, On Target Laboratories, Huake Precision (Beijing) Medical Technology, Averto Medical and Medcura, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a device for blood purification
|
|
| domain | founded_year | HQ Location |
Molecular imaging agents for cancer surgery are developed.
|
|
| domain | founded_year | HQ Location |
Neurosurgery robots are provided for neurological disorder treatments.
|
|
| domain | founded_year | HQ Location |
Medical devices for gastrointestinal disease patients are developed.
|
|
| domain | founded_year | HQ Location |
Developer of the device for controlling bleeding
|
|
| domain | founded_year | HQ Location |
Medical devices for the rapid treatment of bloodstream infections and pathogen-reduction in blood banking
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lindis Blood Care
Frequently Asked Questions about Lindis Blood Care
When was Lindis Blood Care founded?
Lindis Blood Care was founded in 2006 and raised its 1st funding round 13 years after it was founded.
Where is Lindis Blood Care located?
Lindis Blood Care is headquartered in Hennigsdorf, Germany. It is registered at Hennigsdorf, Brandenburg, Germany.
Is Lindis Blood Care a funded company?
Lindis Blood Care is a funded company, having raised a total of $1.89M across 3 funding rounds to date. The company's 1st funding round was a Series A of $1.89M, raised on Dec 13, 2019.
What does Lindis Blood Care do?
Solutions for safer blood transfusions are provided by Lindis Blood Care. Focus is placed on removing tumor and immune cells from blood during cancer surgeries using proprietary ABCR-Technology. The flagship product, CATUVAB, enables safe autologous blood retransfusion, reducing reliance on donor blood. Expansion into markets like EU, US, and Asia is planned. Strategic partnerships for distribution and licensing are sought in various regions. Patient outcomes in oncological surgeries are improved through this technology.
Who are the top competitors of Lindis Blood Care?
Lindis Blood Care's top competitors include Huake Precision (Beijing) Medical Technology, Lumicell Diagnostics and Medcura.
What products or services does Lindis Blood Care offer?
Lindis Blood Care offers CATUVAB®.
Who are Lindis Blood Care's investors?
Lindis Blood Care has 3 investors. Key investors include Investitionsbank des Landes Brandenburg, Brandenburg Capital, and High-Tech Gründerfonds.